抄録
Since 2003, a number of policies and reforms have been implemented in relation to the promotion of research and development in the field of medical science. In the process of applying cutting-edge science and technology to society, clinical research, which is expected to produce findings that lead to social impact, is particularly important, but there are many challenges in Japan. Currently, clinical research is being globalized and conducted through international collaboration; it is necessary in Japan to standardize and introduce transparency to clinical studies as well as to develop infrastructure for enhancing them. The same is true when trying to spread new medical technology within Japan. Thus, there are "death valleys" between cutting-edge medical research and medical service. In April 2015, a new incorporated administrative agency, the Japan Agency for Medical Research and Development was launched to play the central role in implementing, supporting, and managing R&D in the medical field. It is expected to be instrumental in solving a variety of problems. It is inevitable to keep the function of Analysis and Research for evidence-based funding within this organization or, if necessary, to outsource them.
